/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
I'm an early career physician and public health researcher interested in the risk estimation and risk mitigation of cardiovascular diseases at the population level. I started my journey to cardiology by studying risk factors of cardiovascular events in patients with type 2 diabetes. As part of my combined MD-MPH thesis, I studied whether addition of other inflammatory markers can improve current risk stratifications of cardiovascular events or not. Afterwards, I got an early career grant from National Elites Foundation and continued my work on surveillance of non-communicable diseases in Iran. I also served as a co-PI and epidemiologist for a population based cohort called Metabolic Syndrome Complications, and Mortality (MetSCoM). In 2018, I joined One Brave Idea, an initiative by AHA, as a post-doc with the aim of harnessing the power of precession medicine to identify individuals at risk of cardiovascular diseases at early course of disease and offer them targeted therapies.
Hypertensive heart disease burden attributable to high salt intake in the United States compared to the European Union and the global status: trends from 1990 to 2019
Event: ESC Congress 2021 - The Digital Experience
Topic: Epidemiology, Prognosis, Outcome
Session: Congress committee e-posters choice in hypertension
